F. Grollman

Phase I and pharmacokinetic trial of weekly oral fluorouracil given with eniluracil and low-dose leucovorin to patients with solid tumors.

C. Takimoto, J. Grem, J. Shapiro, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

N-(phosphonacetyl)-L-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinoma.

C. Takimoto, J. Grem, C. Allegra, 2001, Annals of Oncology.

High inter- and intrapatient variation in 5-fluorouracil plasma concentrations during a prolonged drug infusion.

D. Venzon, C. Takimoto, J. Grem, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I a nd P harmacokinetic T rial o f W eekly O ral Fluorouracil G iven W ith E niluracil a nd Low-Dose L eucovorin t o P atients W ith S olid T umors

C. Takimoto, J. Grem, J. Shapiro, 2013 .

Phase I and Pharmacokinet ic Tria l o f Weekly Oral Fluorourac i l Given With Eni lurac i l and Low-Dose Leucovor in to Pat ients With Sol id Tumors

C. Takimoto, J. Grem, J. Shapiro, 2000 .

Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors.

L. Grochow, L. Neckers, C. Takimoto, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic Renal Cell Carcinoma

S. Steinberg, J. Berzofsky, W. Linehan, 2010, Journal of Translational Medicine.

Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients.

S. Arbuck, C. Takimoto, J. Grem, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma.

S. Steinberg, P. Johnston, C. Takimoto, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule

E. Szabo, J. Grem, J. M. Hamilton, 2003, Cancer chemotherapy and pharmacology.

Cost savings realized by use of the PhaSeal® closed-system transfer device for preparation of antineoplastic agents

D. Solimando, J. Pang, M. S. Edwards, 2013, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.